Smith Stan 4

What Happened

• Stan Smith, a director of MAIA Biotechnology, Inc. (MAIA), received a grant of 33,099 derivative securities (stock options) on March 31, 2026. The Form 4 shows an acquisition price of $0.00 for the award (common reporting for option grants). The options vest 100% on the grant date and are exercisable as of that date.

Key Details

• Transaction date: 2026-03-31; Form 4 filed: 2026-04-02 (appears timely).
• Award: 33,099 stock options; filing lists acquisition price $0.00 (derivative award).
• Vesting/exercise: Options vest 100% on grant date and are immediately exercisable (Footnote F1).
• Beneficial ownership: Securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993 (Footnote F2).
• Shares owned after transaction: Not specified in the filing.

Context

• This was an equity award (grant of options), not a purchase or sale of shares. Because the options vest immediately and are exercisable, Mr. Smith could choose to exercise them, which would be reported separately if/when exercised or sold. Grants are routine compensation for insiders and do not by themselves indicate a purchase or sale sentiment.